Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-56,166
Closed -$22.9M 3710
2025
Q4
$17.6M Buy
56,166
+22,718
+68% +$7.21M 0.06% 268
2025
Q3
$9.03M Sell
33,448
-7,457
-18% -$1.71M 0.03% 428
2025
Q2
$9.02M Buy
40,905
+8,369
+26% +$1.51M 0.04% 341
2025
Q1
$4.27M Buy
32,536
+5,143
+19% +$718K 0.03% 497
2024
Q4
$3.75M Sell
27,393
-20,761
-43% -$2.85M 0.02% 494
2024
Q3
$4.88M Buy
48,154
+11,920
+33% +$943K 0.02% 470
2024
Q2
$2.65M Buy
36,234
+30,228
+503% +$1.98M 0.01% 624
2024
Q1
$303K Buy
+6,006
New +$282K ﹤0.01% 1540
2023
Q4
Sell
-9,105
Closed -$414K 2254
2023
Q3
$414K Sell
9,105
-4,914
-35% -$203K ﹤0.01% 1502
2023
Q2
$552K Buy
+14,019
New +$567K 0.01% 1310
2023
Q1
Sell
-6,917
Closed -$255K 2427
2022
Q4
$255K Buy
+6,917
New +$243K ﹤0.01% 1820
2022
Q2
Sell
-8,212
Closed -$333K 2862
2022
Q1
$333K Buy
+8,212
New +$322K ﹤0.01% 2164
2021
Q2
Sell
-8,513
Closed -$454K 2787
2021
Q1
$454K Sell
8,513
-8,804
-51% -$424K ﹤0.01% 1862
2020
Q4
$770K Buy
+17,317
New +$777K 0.02% 803

Other funds holding AGX

HRT Financial's AGX Position: Q1 2026 in Review

HRT Financial sold out of Argan (AGX) in Q1 2026, closing a stake of 56,166 shares — an estimated $22.9M sold.

HRT Financial first reported a position in AGX in Q4 2020 and held it in 14 quarters. The position peaked at $17.6M in Q4 2025. 496 funds tracked by Wall St. Rank hold AGX as of Q1 2026.

  • HRT Financial reported no remaining Argan position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 56,166 Argan shares in Q1 2026, an estimated $22.9M.
  • HRT Financial first reported a position in Argan in Q4 2020 and held it in 14 quarters.
  • HRT Financial's Argan position peaked at $17.6M in Q4 2025.
  • 496 funds tracked by Wall St. Rank held Argan as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.